Navigation Links
Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells

Comparison of liposome-based transfection reagents


D.J. Lowrie Jr.
Department of Cell Biology, Neurobiology, and Anatomy
University of Cincinnati College of Medicine, Cincinnati, OH 45267


Transfection of mammalian cell lines is enhanced by the use of liposome-based reagents. Here we compare the transfection efficiency of green fluorescent protein into human adrenalcarcinoma cells using both LipoTAXI transfection reagent and LipofectAMINE reagent.

Our lab has recently been interested in the transient transfection of green fluorescent proteins into mammalian cells. We have been using the pEGFP-C3 and pEGFP-N3 vectors, which contain sequences encoding the enhanced version of green fluorescent protein (EGFP) whose expression is driven by the cytomegalovirus (CMV) promoter. Convenient restriction sites in these vectors allow fusion of a protein of interest to either the amino- or carboxy-terminus of EGFP.

The cell line used for many of our experiments is the human adrenalcarcinoma cell line, SW13, which contains vimentin intermediate filaments. A subclone derived from this cell line lacks vimentin expression and is thought to contain no intermediate filament network.1 Although we have previously had success using this cell line for transfection studies using calcium phosphate,2,3 two recent observations have led us to look for new methods that would improve our efficiency. First, we have found that some of our constructs have produced lower transfection efficiencies than others, making it difficult to obtain a suitable number of transfected cells to draw conclusions. Second, we have noticed heterogeneous subcellular localization of some of our fusion proteins in the same set of transfected cells. Presumably, this is due to varying l
'"/>

Source:


Page: All 1 2 3 4

Related biology technology :

1. Highest Transfection Efficiency of an Endotoxin-Sensitive Mammalian Cell Line
2. Optimizing Transfection Conditions for Studying Signal Transduction Pathways
3. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
4. Versatile Transfection Reagent Offers Low Toxicity and Consistent Performance
5. Low-Toxicity, Lipid-Mediated Transfection of Mammalian Cells
6. Mycoplasma Contamination Reduces the Effect of Lipid-Mediated Transfection of Mammalian Cells
7. High-Efficiency Transfections Achieved with New Low-Toxicity Reagent
8. Efficient Transfection of Neurospora Crassa
9. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells
10. Efficient Transfection of Neurospora Crassa
11. Eppendorf Multiporator Transfection Protocols for Eukaryotic Cells

Post Your Comments:
(Date:11/6/2009)...ewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:...today announced updated results from a Phase II st...rcomas metastatic to the lung in a poster presenta... Society Meeting held in Miami Beach, Florida, fro...titled "A Phase II Study of Intravenous REOLYSIN (...
(Date:11/5/2009)...e hybrid . . . , Fuel economy ratings for the ...the www.fueleconomy.gov web site, which Oak Ridg...the U.S. Department of Energy and the U.S. Environ...les on the best fuel economy list are hybrid elect...hway). "This list proves that hybrids have gone ma...
(Date:11/5/2009)...v. 5 DSM Pharmaceutical Products t...liance with Galenix, Saint Jean D,Illac, France, w...nufacturing partner for Galenix commercial product...llaborate on business development opportunities co...ed on the strength of Galenix in drug product deve...
(Date:11/5/2009)...hursday, November 5, 2009 at 4:30 p.m. Eastern Tim...ire-FirstCall/ - OncoGenex Pharmaceuticals, Inc. (...ay reported unaudited financial results for the th...09 and reviewed the Company,s highlights for the t...ated results reflect the operations of OncoGenex T...
Breaking Biology Technology:Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 2DSM Pharmaceutical Products Forms Manufacturing Alliance With Galenix 3OncoGenex Reports Third Quarter 2009 Financial Results 2OncoGenex Reports Third Quarter 2009 Financial Results 3OncoGenex Reports Third Quarter 2009 Financial Results 4OncoGenex Reports Third Quarter 2009 Financial Results 5OncoGenex Reports Third Quarter 2009 Financial Results 6OncoGenex Reports Third Quarter 2009 Financial Results 7OncoGenex Reports Third Quarter 2009 Financial Results 8
...Sales Reach $11.7 Million, PRINCETON, N.J., May 1..., a provider of advanced wound-care products,annou...ch 31, 2008. For the,quarter, sales were up 47 per...the newly acquired First Aid Division. The Company... due primarily to higher than expected,integration...
...Highlights: - IND for liquid formulation, NGX-19...inical development expected in second quarter of 2...n PHN expected in second half ...view for peripheral neuropathic pain, SAN MATEO, ...a biopharmaceutical company focused on developing ...
...Company secures global supply of top-quality custo...nd marketing executive, NEWBURGH, NY, USA and LIV...nics, developer of the i-LIMB Hand, the world,s fi...nic hand, today announced that it has,acquired the...of the unique,and lifelike prosthetic skin that To...
Other Biology Technology:Derma Sciences Reports First Quarter 2008 Results 2Derma Sciences Reports First Quarter 2008 Results 3Derma Sciences Reports First Quarter 2008 Results 4Derma Sciences Reports First Quarter 2008 Results 5NeurogesX Reports First Quarter 2008 Results 2NeurogesX Reports First Quarter 2008 Results 3NeurogesX Reports First Quarter 2008 Results 4NeurogesX Reports First Quarter 2008 Results 5NeurogesX Reports First Quarter 2008 Results 6NeurogesX Reports First Quarter 2008 Results 7Touch Bionics acquires LIVINGSKIN 2Touch Bionics acquires LIVINGSKIN 3
(Date:11/5/2009)...n.Researchers at Yale University have developed sy...immune response to HIV and HIV-infected cells, as ...published online in the Journal of the American C...approaches for these diseases. , The molecules ...V" (ARM-H) and "antibody-recruiting molecule targe...
(Date:11/4/2009)...Although scientists are reluctant to officially en...dence continues to grow about its protective effec... Cancer Prevention Research , a journal of the Ame...sts some reduction in oral cancer. , Vassiliki ... the Department of Thoracic/Head and Neck Medical ...
(Date:11/4/2009)...corridors in the cities of Long Beach and Riversid...preventable childhood asthma, and the true impact ... has likely been underestimated, according to rese...USC). , The study, which appears in an online e... estimated that nine percent of all childhood asth...
Breaking Biology News(10 mins):New synthetic molecules trigger immune response to HIV and prostate cancer 2Does green tea prevent cancer? Evidence continues to brew, but questions remain 2USC study finds big air pollution impacts on local communities 2Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 1Beginning Swim Classes Too Advanced for Many Beginners 3B Swim Instructor Conference Slated 50151 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 1Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 2Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 3Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 4Clavis Pharma Raises NOK 129 Million 28USD 20 Million 29 in a Private Placement to Fund Further Development of its Pipeline of Novel Anticancer Drug 12798 5JustGetTested com Offers Fast Confidential HIV Testing to Mark National HIV Testing Day 50147 1JustGetTested com Offers Fast Confidential HIV Testing to Mark National HIV Testing Day 50147 2
...chers at Yale School of Medicine have found eviden... stimulates the higher brain functions of spatial ...sts that we may learn best on an empty stomach. , ...e Neuroscience by investigators at Yale and other ...lin, produced in the stomach and previously associ...
...ists have found that growth hormone, a substance t...ain, according to an article published in this wee...s. , The researchers -- from three institutions –?...ippocampus, a structure deep inside the brain that...ists also found that more growth hormone is produc...
...eriments with mice, researchers have found that el...ch for the development of pain-sensing neurons kno...." Such pain is abnormal pain that outlasts the in...ervous system changes. The animals rendered defici... response to discomfort caused by heat and cold an...
Other Biology News:Learning and memory stimulated by gut hormone 2Growth hormone is made in the brain, report scientists 2Master genetic switch found for chronic pain 2
Mouse Anti-Human SNAPC5 Monoclonal Antibody, Unconjugated, Clone 6G10 from Abnova Corporation
...Mouse monoclonal antibody raised against a partial...28, 56 a.a. ~ 145 a.a) partial recombinant protein...QHEPFLDFLLGFSAGTEYMDLQNDLGQTALHLAAILGETSTVEKLYAAGA...8 Protein Accession Number: AAH15528 OMIM: ...
...The BD PhosFlow Perm/Wash Buffer I can be used in ...ified signaling proteins to permeabilize cells and...fer. Because saponin-mediated cell permeabilizatio... the cells in the presence of saponin during intra...
Mouse Anti-Human ACTN4 Monoclonal Antibody, Unconjugated, Clone 4D10 from Abnova Corporation
Biology Products: